These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2987362)
1. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4. Wong E; Camp RD; Greaves MW J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362 [TBL] [Abstract][Full Text] [Related]
2. Production of intraepidermal microabscesses by topical application of leukotriene B4. Camp R; Jones RR; Brain S; Woollard P; Greaves M J Invest Dermatol; 1984 Feb; 82(2):202-4. PubMed ID: 6319504 [TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions. Lammers AM; van de Kerkhof PC Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753 [TBL] [Abstract][Full Text] [Related]
4. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin. Lammers AM; van de Kerkhof PC Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322 [TBL] [Abstract][Full Text] [Related]
5. Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE. Norris PG; Schofield O; Dowd PM; Greaves MW Dermatologica; 1987; 174(5):219-23. PubMed ID: 3034690 [TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin. van de Kerkhof PC; Lammers AM; Mier PD; Happle R Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562 [No Abstract] [Full Text] [Related]
7. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin. Dowd PM; Black AK; Woollard PW; Greaves MW Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes. van de Kerkhof PC; Bauer FW; Maassen-de Grood RM Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429 [TBL] [Abstract][Full Text] [Related]
9. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis. Lammers AM; van de Kerkhof PC; Mier PD Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194 [TBL] [Abstract][Full Text] [Related]
10. Intraepidermal accumulation of polymorphonuclear leukocytes in annular pustular psoriasis. van de Kerkhof PC; Lammers AM Dermatologica; 1988; 176(6):282-7. PubMed ID: 2841175 [TBL] [Abstract][Full Text] [Related]
11. Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4. Bauer FW; van de Kerkhof PC; Maassen-de Grood RM Br J Dermatol; 1986 Apr; 114(4):409-12. PubMed ID: 3008801 [TBL] [Abstract][Full Text] [Related]
13. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics. Green CM; Ferguson J; MacLeod TM; Millar BW; Raffle EJ Dermatologica; 1989; 178(1):20-2. PubMed ID: 2537239 [TBL] [Abstract][Full Text] [Related]
14. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes. Lammers AM; van de Kerkhof PC Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858 [TBL] [Abstract][Full Text] [Related]
15. The perivascular cell populations in human skin after topical application of leukotriene B4. Winkelmann RK; Camp R; English JS; Greaves MW Acta Derm Venereol; 1986; 66(4):340-3. PubMed ID: 2430407 [TBL] [Abstract][Full Text] [Related]
16. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions. Fogh K; Herlin T; Kragballe K J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417 [TBL] [Abstract][Full Text] [Related]
17. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent. Larkin SW; Fraser L; Showell HJ; Williams TJ; Warren JB J Pharmacol Exp Ther; 1995 Jan; 272(1):392-8. PubMed ID: 7815355 [TBL] [Abstract][Full Text] [Related]
18. The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry. Glade CP; Botermans RJ; van Erp PE; van de Kerkhof PC Acta Derm Venereol; 1995 Nov; 75(6):437-41. PubMed ID: 8651019 [TBL] [Abstract][Full Text] [Related]
19. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4. Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566 [TBL] [Abstract][Full Text] [Related]
20. The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111). van Pelt JP; de Jong EM; van Erp PE; Mitchell MI; Marder P; Spaethe SM; van Hooijdonk CA; Kuijpers AL; van de Kerkhof PC Biochem Pharmacol; 1997 Apr; 53(7):1005-12. PubMed ID: 9174114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]